BHCM
RGEN icon

Brevan Howard Capital Management’s Repligen RGEN Stock Holding History

Brevan Howard Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,409
Closed -$1.87M – 2435
2025
Q4 		$1.87M Buy
+11,409
New +$1.79M 0.02% 506
2025
Q3 		– Sell
-4,385
Closed -$545K – 2221
2025
Q2 		$545K Buy
+4,385
New +$558K ﹤0.01% 1323
2024
Q3 		– Sell
-3,748
Closed -$472K – 1386
2024
Q2 		$472K Buy
+3,748
New +$587K ﹤0.01% 627

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Brevan Howard Capital Management's RGEN Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 11,409 shares — an estimated $1.87M sold.

Brevan Howard Capital Management first reported a position in RGEN in Q2 2024 and held it in 3 quarters. The position peaked at $1.87M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 11,409 Repligen shares in Q1 2026, an estimated $1.87M.
  • Brevan Howard Capital Management first reported a position in Repligen in Q2 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Repligen position peaked at $1.87M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.